Braille Prescription Labels in the U.S.: Current Status
Braille prescription labels are not federally required in the United States, but there are advisory guidelines and state-level efforts aimed at improving accessibility:
Federal Guidelines
- The FDA Safety and Innovation Act (2012) authorized the U.S. Access Board to develop best practices for accessible prescription labeling, including Braille, large print, and auditory formats like “talking bottles”.
- These recommendations are advisory only, not mandatory. Pharmacies are encouraged—but not required—to offer Braille labels.
- The FDA has approved Braille labeling on specific drugs, such as Hetlioz, but only when submitted by the manufacturer.
State-Level Legislation
Some states have introduced or passed laws requiring accessible prescription labeling, which may include Braille:
- California, Colorado, Virginia, Michigan, and Minnesota have passed laws related to accessible labeling.
- New York (S1740) has introduced legislation for accessible prescription labeling, but it’s not yet law.
- Other states like Texas, Iowa, Missouri, and Illinois have bills in progress.
Pharmacy Practices
- Major chains offer accessible options such as ScripTalk (audible labels) and Braille overlays upon request.
- Pharmacies may partner with others that have Braille embossing capabilities to fulfill occasional requests.